UBS AM
NUTX

UBS AM’s Nutex Health NUTX Stock Holding History

UBS AM’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
2,419
+479
+25% +$58.7K ﹤0.01% 2707
2025
Q4 		$319K Buy
+1,940
New +$257K ﹤0.01% 2406
2025
Q3 		– Sell
-4,833
Closed -$602K – 2486
2025
Q2 		$602K Buy
+4,833
New +$624K ﹤0.01% 2467
2023
Q4 		– Sell
-2,173
Closed -$66K – 2583
2023
Q3 		$66K Hold
2,173
– – ﹤0.01% 2576
2023
Q2 		$329K Hold
2,173
– – ﹤0.01% 2448
2023
Q1 		$329K Hold
2,173
– – ﹤0.01% 2448
2022
Q4 		$619K Buy
+2,173
New +$417K ﹤0.01% 2088

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

UBS AM's NUTX Position: Q1 2026 in Review

UBS AM increased its Nutex Health (NUTX) stake by 25% in Q1 2026, buying an estimated $58.7K and bringing the position to 2,419 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

UBS AM first reported a position in NUTX in Q4 2022 and has held it in 7 quarters since. The position peaked at $619K in Q4 2022. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • UBS AM held 2,419 shares of Nutex Health worth $230K as of Q1 2026.
  • UBS AM bought 479 Nutex Health shares in Q1 2026, an estimated $58.7K.
  • Nutex Health made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2707 holding.
  • UBS AM first reported a position in Nutex Health in Q4 2022 and has held it in 7 quarters since.
  • UBS AM's Nutex Health position peaked at $619K in Q4 2022.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.